Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). | Download Scientific Diagram
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
A Reversible and Selective Inhibitor of Monoacylglycerol Lipase Ameliorates Multiple Sclerosis - Hernández‐Torres - 2014 - Angewandte Chemie International Edition - Wiley Online Library
Overview of current clinical studies of MAGL inhibitor 21 (ABX-1431). | Download Scientific Diagram
The highs of endocannabinoid physiology - The Physiological Society
Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo | PNAS
Discovery of Trifluoromethyl Glycol Carbamates as Potent and Selective Covalent Monoacylglycerol Lipase (MAGL) Inhibitors for Treatment of Neuroinflammation | Journal of Medicinal Chemistry
Pharmaceuticals | Free Full-Text | Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review
Synthesis and biological evaluation of novel tanshinone IIA derivatives for treating pain
APExBIO - MJN110 | MAGL inhibitor | CAS# 1438416-21-7
Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors | Translational Psychiatry
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Chem Soc Rev
Frontiers | Discovering monoacylglycerol lipase inhibitors by a combination of fluorogenic substrate assay and activity-based protein profiling
APExBIO - Monoacylglycerol Lipase Inhibitor 21 inhibitor of monoacylglycerol lipase (MAGL) and FAAH | CAS# 1643657-35-5
Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids - Chemical Society Reviews (RSC Publishing) DOI:10.1039/C4CS00047A
A Schematic model of the effects of MAGL inhibition on the interactions... | Download Scientific Diagram
![Synthesis and Preclinical Evaluation of Sulfonamido-based [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase](https://www.thno.org/v06/p1145/thnov06p1145g004.jpg "Synthesis and Preclinical Evaluation of Sulfonamido-based [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase")
Synthesis and Preclinical Evaluation of Sulfonamido-based [11C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants. - Abstract - Europe PMC
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice - eBioMedicine
